Franklin Resources Inc Vyne Therapeutics Inc. Transaction History

Franklin Resources Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.37 - $0.71 $17,192 - $32,990	-46,466 Reduced 32.58%	96,134 $37,000
Q4 2021 Feb 11, 2022	SELL	$0.91 - $1.5 $1.62 Million - $2.67 Million	-1,778,636 Reduced 92.58%	142,600 $145,000
Q3 2021 Nov 12, 2021	BUY	$1.39 - $3.47 $28,318 - $70,694	20,373 Added 1.07%	1,921,236 $2.67 Million
Q2 2021 Aug 13, 2021	BUY	$3.24 - $6.92 $685,584 - $1.46 Million	211,600 Added 12.53%	1,900,863 $6.67 Million
Q1 2021 May 13, 2021	BUY	$6.34 - $12.68 $10.7 Million - $21.4 Million	1,689,263 New	1,689,263 $11.6 Million

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $170M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.